AU6844296A - Ribozymes targetting hiv and siv - Google Patents
Ribozymes targetting hiv and sivInfo
- Publication number
- AU6844296A AU6844296A AU68442/96A AU6844296A AU6844296A AU 6844296 A AU6844296 A AU 6844296A AU 68442/96 A AU68442/96 A AU 68442/96A AU 6844296 A AU6844296 A AU 6844296A AU 6844296 A AU6844296 A AU 6844296A
- Authority
- AU
- Australia
- Prior art keywords
- targetting
- siv
- ribozymes
- hiv
- targetting hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US550595P | 1995-08-25 | 1995-08-25 | |
US005505 | 1995-08-25 | ||
PCT/US1996/012990 WO1997007667A1 (en) | 1995-08-25 | 1996-08-09 | Ribozymes targetting hiv and siv |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6844296A true AU6844296A (en) | 1997-03-19 |
Family
ID=21716218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU68442/96A Abandoned AU6844296A (en) | 1995-08-25 | 1996-08-09 | Ribozymes targetting hiv and siv |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6844296A (en) |
WO (1) | WO1997007667A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5144019A (en) * | 1989-06-21 | 1992-09-01 | City Of Hope | Ribozyme cleavage of HIV-I RNA |
US5225347A (en) * | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Therapeutic ribozyme compositions and expression vectors |
WO1995004818A1 (en) * | 1993-08-06 | 1995-02-16 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting human immunodeficiency virus replication |
-
1996
- 1996-08-09 AU AU68442/96A patent/AU6844296A/en not_active Abandoned
- 1996-08-09 WO PCT/US1996/012990 patent/WO1997007667A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997007667A1 (en) | 1997-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5619894A (en) | Dna-armed ribozymes and minizymes | |
AU5772196A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
AU5343394A (en) | Orthosis and prosthesis | |
AU663637B2 (en) | Solutions and their preparation | |
AU3655893A (en) | Lateral force resisting structures and connections therefor | |
AU6124296A (en) | Novel dolastatin derivatives, their preparation and use | |
AU5772296A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
AU5772396A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
AU6162896A (en) | Human chemokine beta-11 and human chemokine alpha-1 | |
AU1122797A (en) | Modular desk and desk system | |
AU6120994A (en) | Anticonvulsive agents and uses thereof | |
AU7095296A (en) | Phosphorylamides, their preparation and use | |
AU1916795A (en) | Human chemokine beta-11 and human chemokine alpha-1 | |
AU5652096A (en) | Azacycloalcane derivatives, their preparation and their applications in therapy | |
AU6128896A (en) | Isoindole derivatives, their preparation and their application in therapy | |
AU7544396A (en) | Triazole derivatives and uses thereof | |
AU7529796A (en) | S-nitroso-hemoglobin and therapeutic uses thereof | |
AU5199396A (en) | Polyurethane-polyureas and their use as emulsifiers | |
AU5403594A (en) | Pilin variants and uses thereof | |
AU2512495A (en) | Therapeutic phenoxyalkylazoles and phenoxyalkylazines | |
AU6975996A (en) | Stabilized agchemical concentrate and use thereof | |
AU5188296A (en) | Carbopeptoids and carbonucleotoids | |
AU6844296A (en) | Ribozymes targetting hiv and siv | |
AU698333B2 (en) | Spool and wedge assembly |